Delivery Order SPE2DE24DA010-SPE2D626F69Q0
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,495 on December 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority has a performance completion date of January 6, 2026, and will be performed in Santa Clara, California. The award carries no set-aside designation and was made through full and open competition, consistent with Abbott Vascular's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $5,695.00 from the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes a fixed-price structure with economic price adjustment pricing and was awarded without a set-aside designation through full and open competition. Performance will take place in Santa Clara, California, positioning the award...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $5,495.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025. This child contract is a delivery order with an ultimate completion date of January 6, 2026, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, reflecting Abbott's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $17,250 from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price contract with economic price adjustment provision will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation. As a child entity of Abbott Laboratories Inc., Abbott...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract (4570382323 GALLANT) valued at $25,875.85 on December 11, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price contract with economic price adjustment terms is scheduled for completion by January 6, 2026, and will be performed in Santa Clara, California. The contract utilizes no set-aside designation and was awarded through full and open competition, reflecting...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F69Q0Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order contract award on December 11, 2025, with an ultimate completion date of January 6, 2026. The contract, valued at $5,695.00, was issued by the Defense Logistics Agency's Medical Supply Chain under a fixed-price with economic price adjustment structure. The place of performance is Santa Clara, California 95054. No set-aside designation was used in this award, reflecting Abbott's competitive positioning in full and open competition for federal healthcare procurement. This delivery order represents a task order against Abbott Vascular's broader Indefinite Delivery Contract with the Defense Logistics Agency, which is valued at $117.1 million and covers comprehensive cardiovascular procedural packages including devices, instrumentation, accessories, and related medical technologies. Abbott Vascular has established itself as a critical supplier of advanced cardiovascular medical devices to federal healthcare systems, including stents, pacemakers, heart valves, implantable cardiac monitors, left ventricular assist devices, and transcatheter valve repair systems. The company maintains a substantial portfolio of federal contracts across multiple Veterans Integrated Service Networks, the Defense Health Agency, and other federal healthcare agencies, positioning it as an essential element of the federal government's medical supply infrastructure for supporting complex cardiovascular procedures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/10/25 |